Influenza vaccine

Afluria, Afluria Quadrivalent

225UG InjectionUnited StatesNot marketedAuthorised 28 Sept 2007

In other countries

The same active substances on other registers, the same brand first.

Influvac Tetra (2026 formulation)New Zealand · Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)Same form
Influvac Tetra (2026 formulation)New Zealand · Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)Same form
FluadEuropean Union · Seqirus Netherlands B.V.Same substance
FlucelvaxEuropean Union · Seqirus Netherlands B.V.Same substance
FluenzEuropean Union · AstraZeneca ABSame substance
Agrippal S1 45MG\0.5ML Pre-Filled SyringSaudi Arabia · Novartis Vaccine and Diagnostics S.R.ISame substance
FLUARIX 15McgOF ECH INFUENZA STR.5MLSRYGSaudi Arabia · Glaxosmithkline (GSK)Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Influenza vaccine

Afluria, Afluria Quadrivalent

225UG InjectionUnited StatesNot marketedAuthorised 28 Sept 2007

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Influenza vaccine
Strength: 225UG
Dosage form: Injection
Route: Intramuscular
Register: United States (FDA)
Status: Not marketed
Status in the register: Licensed / Disc
Authorised: 28 Sept 2007
Registration: BLA 125254
Marketing authorisation holder: Seqirus Pty Ltd.
Procedure: 351(a)
Supply: Disc

FlublokInfluenza vaccine · 135UG/.5ML · InjectionUnited States

FlublokInfluenza vaccine · 180UG/.5ML · InjectionUnited States

Flucelvax, Flucelvax QuadrivalentInfluenza vaccine · 45UG/.5ML · InjectionUnited States

Flulaval, Flulaval QuadrivalentInfluenza vaccine · 45UG/.5ML · InjectionUnited States

Afluria, Afluria QuadrivalentInfluenza vaccine · 45UG/.5ML · InjectionUnited States

Afluria, Afluria QuadrivalentInfluenza vaccine · 60UG/.5ML · InjectionUnited States

Afluria, Afluria QuadrivalentInfluenza vaccine · 30UG/.25ML · InjectionUnited States

Afluria, Afluria QuadrivalentInfluenza vaccine · 60UG/.5ML · InjectionUnited States

Fluarix, Fluarix QuadrivalentInfluenza vaccine · 60UG/.5ML · InjectionUnited States